Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs – Markets Insider
|
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Markets Insider He continued, “We view the Replimune management team as the most experienced in the oncolytic immunotherapy field, having developed the first and only oncolytic product to obtain approval by the FDA.” Replimune also separately announced today the … Replimune Appoints Howard L. Kaufman, MD, FACS as Chief Medical OfficerPR Newswire (press release) |
|
Research Roundup: Zika virus used to treat brain cancer, improving bladder function after spinal cord injury and more!
Speaking of Research Pioneering gene therapy approved for leukemia in the USA. CAR T is a pioneering type of gene therapy for cancer. CAR T cells are equivalent to given patients a “living drug”. “The therapy requires drawing blood from patients and separating out the T cells. |
|
UPDATE 1-Roche blood test could help ‘personalise’ cancer …
Business Insider MADRID, Sept 8 (Reuters) – A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a … |
WHTC |
UPDATE 1-Roche blood test could help ‘personalise’ cancer immunotherapy
Reuters Evidence shows that tumours with more mutations are more likely to respond to immunotherapy, Roche said, adding that it hopes the new test will improve measuring TMB, particularly when invasive biopsies are not feasible. There are no such blood tests … Roche blood test could help ‘personalize’ cancer immunotherapy …WHTC Roche blood test can accurately predict immunotherapy efficacyPharmaTimes |
Nasdaq |
Roche blood test could help ‘personalise’ cancer immunotherapy
Nasdaq Evidence shows that tumours with more mutations are more likely to respond to immunotherapy, Roche said, adding that it hopes the new test will improve measuring TMB, particularly when invasive biopsies are not feasible. There are no such blood tests … Roche blood test could help ‘personalize’ cancer immunotherapy …WHTC Immunooncology: Roche presents blood biomarker testEuropean Biotechnology |
Bloomberg |
Does Immunotherapy Offer Hope to Finally End Cancer? – Bloomberg
Bloomberg Bloomberg’s Anna Edwards reports on the earthquake registering 8.0 that shook Mexico. The quake hit off the coast of Chipas state. (Source: Bloomberg) |